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Summary: A method is described for the semi-automated measurement of inulin concentrations in serum and urine
in the presence of glucose. The concentration of glucose is measured simultaneously and is used to correct for
almost all "inulin-like" interferences. The inulin Standard curve is linear over a wide ränge (5—2500 mg/1). Between-
run precision is < 6% and recovery from spiked sera is 98%. This method offers the possibility of measuring
glomerular filtration rate in patients with varying glucose concentrations (e. g. diabetics).
Introduction
Inulin is an uncharged fhictose polymer with an average
relative molecular mäss of 5200. It does not bind to
plasma proteins and distributes freely in the extracellular
fluid. Inulin is eliminated by filtration through the glo-
merulus and is not reabsorbed, secreted or metabolised
at the tubulus. Thus, renal inulin clearänce using a con-
stänt infusion is the "gold Standard" for measuring glo-
merular filtration rate, any extrarenal elimination being
stable with constant plasma inulin concentrations (1).
Most methods for the meäsufement of inulin in plasma
or urine are based on the estimatioii of fhictose. Inulin
is hydrolysed to fhictose in a protein free filtrate, fol-
löwed by a coloripietric assay of fhictose using ß-indo-
lylacetic acid (2), resorcinol (3) or anthrone (4).
Carbohydrates, especially glucose, imteffere with these
methods by increasing the absorbance, resülting in an
overestimation of the inulin concentration. Unstable
plasma glucose eoncentrations, which may occur in dia-
betics, result in additional errors, which may be en-
hanced if glycosuria develops when plasma glucose con-
centrations are above the renal threshold. Obviously this
excludes the use of the inulin clearanee test for these
patients. To overcome this problem glucose has been
eliminated enzymatically prior to the test (5). Alternative
methods have been developed using speciific enzymatic
assays (6, 7), or refined techniques such äs HPLC (8),
requiring special equipment.
We developed a semi-automated method for inulin de-
termination in serum and urine samples, in which the
glucose concentration in measured simultaneously. In




1. Standard inulin Solutions: Inulin from Merck (Darmstadt, Ger-
many) was dried in a desiccator for at least 48 hours and dissolved
in (hol) water to make a 10000 mg/1 Standard solution. From this a
200, 400, 600, 800 and 1000 mg/1 working Standard was prepared.
2. Glucose Standard Solutions: Glucose was purchased from Merck,
the following Standard Solutions were made: 2.5, 5, 10 and 20
mmol/1.
3. Anthrone solution. Two grams of anthrone (Sigma) was dis-
solved in 700 g/kg sulphuric acid. The solution was stored in the
dark and was stable for at least l week.
4. Reagents of p. a. quality were obtained from Merck, unless
otherwise specified.
5. Boehringer Mannheim D-glucose/D-fructose Test Combination
'(Cat. No. 139106), for the determination of inulin in urine and
serum after acid hydrolysis.
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Fig. l Flow diagram of the autoanalyser.
For explanation of the components of the flow diagram and the
sample flow see text.




(1.00 ml/min), 3, 6 orange green (0.10 ml/min), 8, 10 yellow/yel-
low (1.20 ml/min) and 9 orange/orange (0.42 ml/min). Abbrevi-
ations: DMC: double mixing coil; SMC: single mixing coil.
General description of the method
Urine samples are diluted four times with water. Then serum or
diluted urine is deproteinized and placed in a sample cüp.
After aspiration the inulin in the sample is hydrolysed to fructose
in 700 g/kg sulphuric acid for 5 min in a heating bath. Fructose
reacts with anthrone to produce a blue-green compound. Its con-
centration is determined by measuring the absorbance at 630 nrn.
Glucose is determined in a parallel sample stream. The inulin-like
absorbance of the glucose Standards measured in the inulin-assay-
unit is used to construct a glucose correction curve.
V*
Flow procedure in the autoanalyser
The following units of the Autoanalyser are used: sampler, pumps,
single and double mixing coils, heating baths, colorimeters and re-
corders.
Because inulin cannot be dialysed in this System, a sample (0.2
ml) is deproteinized manually by the addition of 1.8 ml trichloro-
acetic acid (50 g/l). After mixing and centrifugation (5min,
2000 g) a portion of the supernatant is placed in a sample cup.
Inulin Standards are processed the same way äs serum samples.
Each sample is diluted 10-fold with water in the predilution cart-
ridge (fig. 1), then mixed in a double mixing coil, after which the
sample stream is split: one part enters the glucose analysing unit
("blank cartridge") using the Standard method frorn Technicon for
measurement of glucose with hexokinase. The other part enters the
inulin analysing unit ("assay cartridge").
In the assay cartridge the diluted sample is mixed with 700 g/kg
sulphuric acid in a double mixing coil. Then anthrone solution is
added. After complete mixing in a single mixing coil, the solution
enters the first heating bath at 90 °C, and after 2.85 min the second
bath at 50 °C for 2.15 min. By using two baths to lengthen the
mcubation time, we were able to increase the ränge of the calibra-
tion line. The colorimetric reading is performed in a 1.5 mm flow
cell, with a 630 mm filter. The acid and anthrone Solutions are
aspirated frorn the Containers by acidflex tubing.
Sampling time is 90 s. Between two samples, the sampling probe
is rinsed and water is aspirated for 90 s. We constructed the inulin °
and glucose Standard curve with five Standard Solutions of inulin
and five Standard Solutions of glucose respectively.
Patient material
Four patients with chronic renal^failure and 2 patients with non-
insulin-dependent diabetes mellitus received an inulin dose of 75
mg/kg lean body mass (9) by intravenous infusion during 5 min.
The characteristics of the patients are shown in table l. A "pre-
inulin" blank sample frorn every patient was analysed for inulin,
corrected for glucose interfererice, and the remaining "inulin-like"
(which is of non-glucose and non-inulin origin) concentration was
subtracted frorn the inulin concentration in the subsequent samples.
In both diabetic patients the interference of an exogeneous dose of
glucose on the inulin concentrations was studied by giving a 25 g
glucose solution intravenously at t = 180 min. Serum inulin con-
centrations corrected for glucose were compared with senim inulin
concentrations not corrected for glucose.
Stastistical analysis
Orthogonal regression analysis was performed according to Dem-
10 15- 20 25
Glucose [mmol/l]
Fig. 2 The interference of glucose in inuh'n determinations.
Apparent inulin concentrations due to glucose interference in the
inulin assay, äs measured in the sera of 36 patients not receiving
inulin. (y = 5.9x + 20.8; r =
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* Autosornal dominant polycystic kidney disease. Non-insulin-dependent.
Results
Methodology
Within-run precision is better than 0.5% in the low and
the high ränge of the calibration curve. Between-run
precision, measured each day at two levels for 20 days,
is 5.8% at 165 mg/1 and 2.7% at 400 mg/1. The lowest
measurable concentration is 5 mg/1, but sensitivity can
be easily increased 10 times by omitting prior dilution
or by increasing the sensitivity of the colorimeter.
Recovery experiments performed in eight different sera
spiked with inulin show a recovery of 98 ± 1%. Only
minor sample carryover could be detected: inulin con-
centration increases by 6 mg/1 (SD 2 mg/1, n = 10) in
the sample pipetted directly after a 1000 mg/1 sample.
The inulin calibration curve is linear over the ränge from
0 to 2500 mg/1 äs checked with 13 Standards, the coeffi-
cient of correlation being r = 0.997.
Glucose interference was investigated, using 36 inulin-
free patient serum samples, with different glucose con-
centrations. The apparent inulin levels in these sera
show a linear relationship, äs indicated in figure 2. Also
endogenous fructose in the patient samples will contrib-
ute to the apparent inulin concentration. Using fructose
Standards in water, the foljowing relation was calculated:
capp. inulin = 175 X Cfructose ~~ 4.8
with inulin in mg/1 and fructose in mmol/1. Correlation
of this method (y) with the Boehringer Mannheim inulin
method (x) gave the foljowing relation:
for serum: y = 0.94x * 29 (Sy/x = 38; n = 20, ränge
ofx: 20-600), and
for urine: y = 0.9 1
ofx: 13^2700),
Patient studies
34 (Sy/x = 195; n = 23, ränge
The glomerular filtration rate in patients with different
degrees of chronic renal failure, äs shown by the creati-
nine clearance, are shown in table 1. As is clear from
this table, creatinine clearance overestimates true glo-
merular filtration rate (inulin clearance).
The serum concentration profile of inulin, with and
without correlation for glucose in two patients with non-
insulin-dependent diabetes mellitus is shown in figure





Fig. 3 Serum inulin and glucose profües in two diabetics.
Serum concentration profiles of inulin in time without (A) and with
(O) correction for glucose interference, together with the serum
glucose concentration curve (4) in two patients with non-insulin-
dependent diabetes mellitus (table 1). Glucose (25 g) was infused
from t = 180 to 200 min, The lower profile is from patient E, the
other is patient F.
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extrapolated curve. The uncorrected serum inulin levels,
however, show an increase at the terminal elimination
phase due to the rise in serum glucose.
Discussion and Conclusion
Methodology
The semi-automated method for determining inulin in se-
rum and urine proved to be reliable if corrected for in-
terfering endogenous glucose. The intra- and inter-assay
reproducibility is excellent. The assay ällows the sequen-
tial determination of the broad ränge of serum and urine
inulin concentrations that is encountered when inulin de-
cay curves are used in the determination of glomerular
filtration rate (11). No individual dilution Steps are re-
quired. The necessary deproteinization of serum must be
performed manually, but this can be done during spare
time, since the samples are stable for at least a week.
From the 'data in figure 2, it can be calculated that with-
out correction 10 mmol/1 glucose will increase the inulin
concentration by 59 mg/1. The intercept of 21 mg/1 (fig.
2) is not caused by the non-serum matrix of the glucose
Standards. Considering the formula describing the rela-
tion between the apparent inulin and the fructose con-
centration, the intercept can be fiilly explained by the
endogenous fructose concentration in the serum: the 21
mg/1 apparent inulin results from the reaction of
anthrone with 0.12 mmol/1 fructose (fructose concentra-
tions in serum ränge from 0.05 to 3.3 mmol/1 (12)). The
method shows good correlation with the Boehringer
Mannheim assay. The latter corrects not only for glucose
but also for fructose, and this may be why our method
gives somewhat higher results for patient samples. The
enzymatic method described by Kuehnle et al. has the
advantage not using aggressive chemicals, but this
method shows also interferenee by endogenous glucose
and fructose (not mentioned by the authors). When the
enzyme, inulinase, becomes commercially available, the
enzymatic method will be very»promising.
Patient studies
The ratio of creatinine to inulin clearance is greater than
one in all patients (tab. 1). This is caused by tubular
excretion of creatinine in addition to glomerular filtra-
tion (1). In calculating true glomerular filtration rate,
correction for endogenous glucose is required beeause
the apparent inulin concentration due to glucose inteifer-
ence may contribute up to 50% of the inulin concentra-
tion, especially when levels are low in the terminal elim-
ination phase (fig. 3). M diabetics this may cause erron-
eously high or low inulin concentrations due to Variation
in blood glucose concentratioiis. With the glucose cor-
rection, the accuracy of the method in these diäbetic pa-
tients improves, especially in the lower inulin ränge.
This is in agreement with others (5), who compafed a
colorimetric assay with a/ specific enzymatic assay and
foünd perfect agreement for low inulin concentrations,
only after prior removäl of glucose. The resulting clini-
cally important advantage is that by cörrecting for glu-
cose in each individual sample, the method is suitable
for use with diabetics.
In conclusion, this method of measuring inulin coneen-
trations in serum and urine is easy to perform, its accu-
racy and reproducibility are better than previously re-
ported (2—4), and it can be used for investigations of
patients with varying glucose concentrations, like dia^
betics.
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